(Q33694525)

28 July 2017

title

Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing (English)

1 reference

inflammatory bowel diseases

28 July 2017

main subject

0 references

author name string

Kumar Krishnan

series ordinal

1

1 reference

28 July 2017

Baron Arnone

series ordinal

2

1 reference

28 July 2017

Alan Buchman

series ordinal

3

1 reference

28 July 2017

language of work or name

1 reference

1 January 2011

1 reference

Inflammatory Bowel Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

410-422

1 reference

Tgf-beta superfamily signaling in embryonic development and homeostasis

28 July 2017

cites work

1 reference

Specificity and versatility in tgf-beta signaling through Smads

21 January 2018

1 reference

TGF-beta: from latent to active

21 January 2018

1 reference

Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms

21 January 2018

1 reference

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors

21 January 2018

1 reference

How the Smads regulate transcription

21 January 2018

1 reference

Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation

21 January 2018

1 reference

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells

21 January 2018

1 reference

A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.

21 January 2018

1 reference

Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats.

21 January 2018

1 reference

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

Signaling pathways activated by the growth hormone receptor

21 January 2018

1 reference

Identification of the first patient with a confirmed mutation of the JAK-STAT system.

21 January 2018

1 reference

Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent

21 January 2018

1 reference

Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I.

21 January 2018

1 reference

Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis.

21 January 2018

1 reference

Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone

21 January 2018

1 reference

The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats: an experimental study

21 January 2018

1 reference

Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

21 January 2018

1 reference

Effect of administered human growth hormone on growth retardation in inflammatory bowel disease.

21 January 2018

1 reference

EGF-ERBB signalling: towards the systems level

21 January 2018

1 reference

Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation

21 January 2018

1 reference

Phosphotyrosine interactome of the ErbB-receptor kinase family

21 January 2018

1 reference

A quantitative protein interaction network for the ErbB receptors using protein microarrays

21 January 2018

1 reference

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

21 January 2018

1 reference

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

21 January 2018

1 reference

Cellular signaling by fibroblast growth factor receptors

21 January 2018

1 reference

Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways

21 January 2018

1 reference

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway

21 January 2018

1 reference

Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)

21 January 2018

1 reference

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

21 January 2018

1 reference

Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice

21 January 2018

1 reference

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

21 January 2018

1 reference

Modulation of specific intestinal epithelial progenitors by enteric neurons

21 January 2018

1 reference

The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways

21 January 2018

1 reference

Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa

21 January 2018

1 reference

Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase.

21 January 2018

1 reference

Enteroendocrine localization of GLP-2 receptor expression in humans and rodents

21 January 2018

1 reference

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion

21 January 2018

1 reference

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

21 January 2018

1 reference

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

21 January 2018

1 reference

Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family.

21 January 2018

1 reference

Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor

21 January 2018

1 reference

Identification of GM-CSF in Paneth cells using single-cell RT-PCR.

21 January 2018

1 reference

Colony-Stimulating Factor-1 Promotes Clonogenic Growth of Normal Murine Colonic Crypt Epithelial Cells In Vitro

21 January 2018

1 reference

Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor

21 January 2018

1 reference

Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.

21 January 2018

1 reference

Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis

21 January 2018

1 reference

Sargramostim for active Crohn's disease

21 January 2018

1 reference

Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.

21 January 2018

1 reference

An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease

21 January 2018

1 reference

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF.

21 January 2018

1 reference

VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.

21 January 2018

1 reference

21 January 2018

1 reference

Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein

21 January 2018

1 reference

Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration.

21 January 2018

1 reference

Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines

21 January 2018

1 reference

Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage.

21 January 2018

1 reference

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor

21 January 2018

1 reference

Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis

21 January 2018

1 reference

Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis

21 January 2018

1 reference

Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice.

21 January 2018

1 reference

Isolation and structure of urogastrone and its relationship to epidermal growth factor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21316

1 reference

28 July 2017

1 reference